Label
Latest ELI LILLY AND COMPANY Patents:
- MODIFIED OLIGONUCLEOTIDES
- Oxyntomodulin binding molecules, and uses thereof
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
- Cocrystalline forms of FGFR3 inhibitors
- Drug container systems including lock-out mechanisms
The patent or application file contains at least one drawing executed in color. Copies of this patent or application with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
The greyscale shading in the Figures represents a contrast in appearance.
Claims
The ornamental design for a label, as shown and described.
| D432245 | October 17, 2000 | Stevens |
| D435662 | December 26, 2000 | Stevens |
| D435663 | December 26, 2000 | Stevens |
| D435664 | December 26, 2000 | Stevens |
| D436182 | January 9, 2001 | Stevens |
| D436183 | January 9, 2001 | Stevens |
| D588200 | March 10, 2009 | Langan |
| D593613 | June 2, 2009 | Langan |
| D595361 | June 30, 2009 | Langan |
| D597608 | August 4, 2009 | Langan |
| D602534 | October 20, 2009 | Langan |
| D605228 | December 1, 2009 | Langan |
| D605229 | December 1, 2009 | Langan |
| D607941 | January 12, 2010 | Langan |
| D614703 | April 27, 2010 | Langan |
| D621879 | August 17, 2010 | Langan |
| D621880 | August 17, 2010 | Langan |
| D624595 | September 28, 2010 | Langan |
| D624596 | September 28, 2010 | Langan |
| D633151 | February 22, 2011 | Langan |
| D634367 | March 15, 2011 | Langan |
| D634368 | March 15, 2011 | Langan |
| D634369 | March 15, 2011 | Langan |
| D639861 | June 14, 2011 | Langan |
| D639862 | June 14, 2011 | Langan |
| D639863 | June 14, 2011 | Langan |
| D641421 | July 12, 2011 | Langan |
| D641422 | July 12, 2011 | Langan |
| D643468 | August 16, 2011 | Langan |
| D643469 | August 16, 2011 | Langan |
| D643470 | August 16, 2011 | Langan |
| D643471 | August 16, 2011 | Langan |
| D643472 | August 16, 2011 | Langan |
| D645094 | September 13, 2011 | Langan |
| D661742 | June 12, 2012 | Clark |
| D677732 | March 12, 2013 | Clark |
| 8734394 | May 27, 2014 | Adams |
| D739011 | September 15, 2015 | Morrison, Jr. et al. |
| D773650 | December 6, 2016 | Fourt et al. |
| 9872961 | January 23, 2018 | Fourt |
| 10350362 | July 16, 2019 | Dennis, Jr. |
| D860472 | September 17, 2019 | Blake |
| D861796 | October 1, 2019 | Hahn |
| D898900 | October 13, 2020 | Atterbury et al. |
| D905788 | December 22, 2020 | Kumar |
| 11065386 | July 20, 2021 | Atterbury |
| D942544 | February 1, 2022 | Banh |
| 015003050-0001 | November 2022 | EM |
| 6243007 | November 2022 | GB |
| 6243008 | November 2022 | GB |
| 6243009 | November 2022 | GB |
| 6243010 | November 2022 | GB |
| 6243011 | November 2022 | GB |
| 6243158 | November 2022 | GB |
- “How to Use the Trulicity Pen for Type 2 Diabetes | Trulicity (dulaglutide),” www.trulicity.com/how-to-use. Accessed Jun. 10, 2022.
- Linjawi, S., What Is Trulicity (Dulaglutide) And How Does It Work?, My Health Explained, accessed Jul. 14, 2023 at https://www.myhealthexplained.com/diabetes-information/diabetes-videos/trulicity-how-do-i-use-it-and-what-does-it-do, (published Sep. 28, 2021 as indicated by Wayback machine).
- Tamble, Mounjaro Weight Loss Online Prescription, accessed Nov. 3, 2023 at https://www.weightlossmounjaro.net/mounjaro-weight-loss-online-prescription/.
Type: Grant
Filed: Nov 6, 2023
Date of Patent: Jul 15, 2025
Assignee: ELI LILLY AND COMPANY (Indianapolis, IN)
Inventors: Frank N. Hockmuller (Noblesville, IN), Julia Freitag McGreevy (Jersey City, NJ), Ross Stephen Merkel (Fishers, IN), Joseph Vito Primiani (Astoria, NY), NatalieAnn DeWitt Rich (New York, NY), J Geoffrey Swope (Indianapolis, IN)
Primary Examiner: Catherine Ho
Application Number: 29/915,908